Type:Notice
Citation:90 FR 10730
Reading Time:about a minute or two
Sharp Clinical Services, LLC has submitted an application to register as an importer of certain controlled substances. The purpose of this registration is to import these substances for distribution and clinical trials, but not for commercial sales of finished products. The public can submit comments or objections electronically until March 28, 2025, and requests for a hearing on the application must be sent to the Drug Enforcement Administration by the same date.
Simple Explanation
Sharp Clinical Services, LLC wants to bring in special medicines that they can use for tests, but they won't sell them in stores; people can tell the government if they have any thoughts or questions until March 28, 2025.